The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel October 22, 2013. Novartis raised its full-year outlook for a second quarter in a row on Tuesday due to the ongoing absence of generic competition to its best-selling blood pressure pill Diovan. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: DRUGS SOCIETY BUSINESS LOGO) - RTX14J87
© 2017 Thomson Reuters. All rights reserved.
Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.